Endolytix
Boston, United States · $9.3M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- endolytx.bio
- Total Funding
- $9.3M
- Last Round
- $5.0M Growth EquityOct 2024
- Rounds
- 3
About
Biotech company developing novel therapeutics to treat antibiotic-resistant infections, with a focus on non-tuberculous mycobacterial (NTM) disease.
Summary
Endolytix is a Biotech company based in Boston, United States. It has raised $9.3M in total across 3 rounds, most recently a $5.0M Growth Equity round in Oct 2024. Investors include Morningside Group and Kineticos AMR Accelerator Fund I.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.